InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal” Sep 4, 2015 05:49PM
InSite Vision to Merge With Canadian Biotechnology Company QLT Jun 8, 2015 11:02AM